Compare companies

Pick 2–4 companies for a side-by-side spec sheet.

Selected: 1 / 4

Side by side

FieldPathos AI
Categories
healthcaredrug-discoverydata-analytics
HQNew York, United States
Founded2021
Latest valuation—
Annual Recurring Revenue (ARR)—
Funding to date$467M
Headcount—
Profitability—
Statusactive
Pricing tierenterprise
DescriptionPathos AI develops machine learning platforms for translational and computational biology, enabling drug discovery and development at scale. The company raised $467M across three rounds, achieving the highest average per-round capital of any active private AI drug discovery company.